Literature DB >> 30408590

Astrocytic expression of the chaperone DNAJB6 results in non-cell autonomous protection in Huntington's disease.

Matteo Bason1, Melanie Meister-Broekema1, Niels Alberts1, Pascale Dijkers1, Steven Bergink1, Ody C M Sibon1, Harm H Kampinga2.   

Abstract

Several neurodegenerative diseases like Huntington's, a polyglutamine (PolyQ) disease, are initiated by protein aggregation in neurons. Furthermore, these diseases are also associated with a multitude of responses in non-neuronal cells in the brain, in particular glial cells, like astrocytes. These non-neuronal responses have repeatedly been suggested to play a disease-modulating role, but how these may be exploited to delay the progression of neurodegeneration has remained unclear. Interestingly, one of the molecular changes that astrocytes undergo includes the upregulation of certain Heat Shock Proteins (HSPs) that are classically considered to maintain protein homeostasis, thus resulting in cell autonomous protection. Previously, we discovered DNAJB6, a member of the human DNAJ family, as potent cell autonomous suppressor of PolyQ aggregation and related neurodegeneration. Using cell type specific expression systems in D. melanogaster, we show that exclusive expression of DNAJB6 in astrocytes (that do not express PolyQ protein) can delay neurodegeneration and expands lifespan when the PolyQ protein is exclusively expressed in neurons (that do not co-express DNAJB6 themselves). This provides direct evidence for a non-cell autonomous protective role of astrocytes in PolyQ diseases.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggregation; Astrocytes; Chaperones; DNAJB6; Neurodegeneration; Polyglutamine; Prion-like aggregate spreading

Year:  2018        PMID: 30408590     DOI: 10.1016/j.nbd.2018.10.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  6 in total

Review 1.  Neuromuscular Diseases Due to Chaperone Mutations: A Review and Some New Results.

Authors:  Jaakko Sarparanta; Per Harald Jonson; Sabita Kawan; Bjarne Udd
Journal:  Int J Mol Sci       Date:  2020-02-19       Impact factor: 5.923

Review 2.  The Host Heat Shock Protein MRJ/DNAJB6 Modulates Virus Infection.

Authors:  Shih-Han Ko; Li-Min Huang; Woan-Yuh Tarn
Journal:  Front Microbiol       Date:  2019-12-11       Impact factor: 5.640

3.  Genetic Screen in Adult Drosophila Reveals That dCBP Depletion in Glial Cells Mitigates Huntington Disease Pathology through a Foxo-Dependent Pathway.

Authors:  Elodie Martin; Raheleh Heidari; Véronique Monnier; Hervé Tricoire
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 4.  Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.

Authors:  Chaebin Kim; Ali Yousefian-Jazi; Seung-Hye Choi; Inyoung Chang; Junghee Lee; Hoon Ryu
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

5.  Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis.

Authors:  Gábor Fidler; Anna Anita Szilágyi-Rácz; Péter Dávid; Emese Tolnai; László Rejtő; Róbert Szász; Szilárd Póliska; Sándor Biró; Melinda Paholcsek
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

6.  The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice.

Authors:  Brígida R Pinho; Ana I Duarte; Paula M Canas; Paula I Moreira; Michael P Murphy; Jorge M A Oliveira
Journal:  Free Radic Biol Med       Date:  2019-11-18       Impact factor: 7.376

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.